Sunshine Biopharma (SBFM) Interest Coverage Ratio (2012 - 2024)
Sunshine Biopharma (SBFM) reported Interest Coverage Ratio of 238.92 for Q4 2024, down 505.93% on a YoY basis from 58.86 in Q1 2024, and up 95.38% quarter-over-quarter from 5176.64 in Q2 2024.
Sunshine Biopharma (SBFM) Interest Coverage Ratio (2012 - 2024) Analysis & Trends
Sunshine Biopharma has reported Interest Coverage Ratio for 12 years, with the latest figure at 238.92 in Q4 2024.
- For the quarter ending Q4 2024, Interest Coverage Ratio fell 505.93% year-over-year to 238.92; the trailing twelve-month figure through Sep 2025 stood at 759.14 (down 1129.11% YoY), and the FY2024 full-year result was 662.43, down 1800.74% from the prior year.
- Interest Coverage Ratio for Q4 2024 stood at 238.92, up from 5176.64 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 1.99 in Q2 2021, with the low at 858990.0 in Q3 2022.
- Historically, Interest Coverage Ratio has averaged 48104.26 across 5 years, with a median of 26.56 in 2024.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio sank 8109137.82% — and 2023, when it surged 100.0%.
- Sunshine Biopharma's Interest Coverage Ratio stood at 3.26 in 2020, then slumped by 134.44% to 7.63 in 2021, then tumbled by 11429.02% to 880.12 in 2022, then jumped by 95.52% to 39.43 in 2023, then slumped by 505.93% to 238.92 in 2024.
- The last three Interest Coverage Ratio figures came in at 238.92 (Q4 2024), 5176.64 (Q2 2024), and 27.46 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Sunshine Biopharma | 10.94 Mn | 4.03 Mn | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -238.92 |
| Jun 30, 2024 | -5,176.64 |
| Mar 31, 2024 | -27.46 |
| Dec 31, 2023 | -39.43 |
| Sep 30, 2023 | -20.23 |
| Jun 30, 2023 | -304.38 |
| Mar 31, 2023 | -44.53 |
| Dec 31, 2022 | -880.12 |
| Sep 30, 2022 | -858,990.00 |
| Mar 31, 2022 | -95.10 |
| Dec 31, 2021 | -7.63 |
| Sep 30, 2021 | -10.59 |
| Jun 30, 2021 | -1.99 |
| Mar 31, 2021 | -25.66 |
| Dec 31, 2020 | -3.26 |
| Sep 30, 2020 | -3.05 |
| Jun 30, 2020 | -5.31 |
| Mar 31, 2020 | -2.30 |
| Dec 31, 2019 | -10.70 |
| Sep 30, 2019 | -7.28 |